• 1
    Li H, Helm PA, Metcalfe CD. 2010. Sampling in the great lakes for pharmaceuticals, personal care products, and endocrine-disrupting substances using the passive polar organic chemical integrative sampler. Environ Toxicol Chem 29:751762.
  • 2
    Sabourin L, Beck A, Duenk PW, Kleywegt S, Lapen DR, Li H, Metcalfe CD, Payne M, Topp E. 2009. Runoff of pharmaceuticals and personal care products following application of dewatered municipal biosolids to an agricultural field. Sci Total Environ 407:45964604.
  • 3
    Edwards M, Topp E, Metcalfe CD, Li H, Gottschall N, Bolton P, Curnoe W, Payne M, Beck A, Kleywegt S, Lapen DR. 2009. Pharmaceutical and personal care products in tile drainage following surface spreading and injection of dewatered municipal biosolids to an agricultural field. Sci Total Environ 407:42204230.
  • 4
    Topp E, Monteiro SC, Beck A, Coelho BB, Boxall ABA, Duenk PW, Kleywegt S, Lapen DR, Payne M, Sabourin L, Li H, Metcalfe CD. 2008. Runoff of pharmaceuticals and personal care products following application of biosolids to an agricultural field. Sci Total Environ 396:5259.
  • 5
    Lajeunesse A, Gagnon C, Sauve S. 2008. Determination of basic antidepressants and their n-desmethyl metabolites in raw sewage and wastewater using solid-phase extraction and liquid chromatography-tandem mass spectrometry. Anal Chem 80:53255333.
  • 6
    Monteiro SC, Boxall ABA. 2010. Occurrence and fate of human pharmaceuticals in the environment. Rev Environ Contam Toxicol 202:53154.
  • 7
    Metcalfe CD, Alder AC, Halling-Sørensen B, Krogh K, Fenner K, Larsbo M, Straub JO, Ternes TA, Topp E, Lapen DR, Boxall ABA. 2008. Exposure assessment methods for veterinary and human-use medicines in the environment: PEC vs. MEC comparisons. In Kümmerer K, ed, Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks, 3rd ed. Springer-Verlag, Berlin Heidelberg, Berlin, Germany, pp 147171.
  • 8
    O'Connor GA, Elliott HA, Basta NT, Bastian RK, Pierzynski GM, Sims RC, Smith JE. 2005. Sustainable land application: An overview. J Environ Qual 34:7717.
  • 9
    Sabourin L, Duenk P, Bonte-Gelok S, Payne M, Lapen DR, Topp E. 2012. Uptake of pharmaceuticals, hormones and parabens into vegetables grown in soil fertilized with municipal biosolids. Sci Total Environ 431:233236.
  • 10
    McLaughlin A, Belknap A. 2008. Annual Kg quantity of medicinal ingredients distributed and dispensed in Canada: Analysis of intercontinental medical statistics (IMS) data for 2007. Environmental Impact Initiative, Health Products and Food Branch, Health Canada, Ottawa, Ontario.
  • 11
    Venkatakrishnan K, Greenblatt DJ, Von Moltke LL, Schmider J, Harmatz JS, Shader RI. 1998. Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: Dominance of CYP2C19 and 3A4. J Clin Pharmacol 38:112121.
  • 12
    Shen Y, Zhu RH, Li HD, Liu YW, Xu P. 2010. Validated LC-MS (ESI) assay for the simultaneous determination of amitriptyline and its metabolite nortriptyline in rat plasma: Application to a pharmacokinetic comparison. J Pharm Biomed Anal 53:735739.
  • 13
    Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ. 2008. The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Res 42:34983518.
  • 14
    Zhang D, Evans FE, Freeman JP, Duhart B Jr, Cerniglia CE. 1995. Biotransformation of amitriptyline by Cunninghamella elegans. Drug Metab Dispos 23:14171425.
  • 15
    Coudore F, Fialip J, Eschalier A, Lavarenne J. 1994. Plasma and brain pharmacokinetics of amitriptyline and its demethylated and hydroxylated metabolites after acute intraperitoneal injection in mice. Eur J Drug Metab Pharmacokinet 19:511.
  • 16
    Ohshima N, Kotaki H, Sawada Y, Iga T. 1994. Tissue distribution and metabolism of amitriptyline after repeated administration in rats. Drug Metab Dispos 22:2125.
  • 17
    Breyer-Pfaff U, Prox A, Wachsmuth H, Yao P. 1987. Phenolic metabolites of amitriptyline and nortriptyline in rat bile. Drug Metab Dispos 15:882889.
  • 18
    Breyer-Pfaff U, Pfandl B, Nill K, Nusser E, Monney C, Jonzier-Perey M, Baettig D, Baumann P. 1992. Enantioselective amitriptyline metabolism in patients phenotyped for two cytochrome P450 isozymes. Clin Pharmacol Ther 52:350358.
  • 19
    Hulten BA, Heath A, Knudsen K, Nyberg G, Svensson C, Martensson E. 1992. Amitriptyline and amitriptyline metabolites in blood and cerebrospinal fluid following human overdose. J Toxicol Clin Toxicol 30:181201.
  • 20
    Mellström B, von Bahr C. 1981. Demethylation and hydroxylation of amitriptyline, nortriptyline, and 10-hydroxyamitriptyline in human liver microsomes. Drug Metab Dispos 9:565568.
  • 21
    Nałęcz-Jawecki G. 2008. In vitro biotransformation of amitriptyline and imipramine with rat hepatic S9 fraction: Evaluation of the toxicity with spirotox and thamnotoxkit F™ tests. Arch Environ Contam Toxicol 54:266273.
  • 22
    Al-Rajab AJ, Sabourin L, Chapman R, Lapen DR, Topp E. 2010. Fate of the antiretroviral drug tenofovir in agricultural soil. Sci Total Environ 408:55595564.
  • 23
    Sabourin L, Al-Rajab AJ, Chapman R, Lapen DR, Topp E. 2011. Fate of the antifungal drug clotrimazole in agricultural soil. Environ Toxicol Chem 30:582587.
  • 24
    Holman SW, Wright P, Langley GJ. 2010. A rapid methodology for the characterization of dialkyl tertiary amine-n-oxide metabolites using structurally dependent dissociation pathways and reconstructed ion current chromatograms. Anal Chem 82:23472354.
  • 25
    Prox A, Breyer-Pfaff U. 1987. Amitriptyline metabolites in human urine. Identification of phenols, dihydrodiols, glycols, and ketones. Drug Metab Dispos 15:890896.
  • 26
    Dahl ML, Bertilsson L, Nordin C. 1996. Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: Relationship to the CYP2D6 genotype. Psychopharmacol 123:315319.
  • 27
    Ramanathan R, Su AD, Alvarez N, Blumenkrantz N, Chowdhury SK, Alton K, Patrick J. 2000. Liquid chromatography/mass spectrometry methods for distinguishing N-oxides from hydroxylated compounds. Anal Chem 72:13521359.
  • 28
    Tong W, Chowdhury SK, Chen JC, Zhong R, Alton KB, Patrick JE. 2001. Fragmentation of N-oxides (deoxygenation) in atmospheric pressure ionization: Investigation of the activation process. Rapid Commun Mass Spectrom 15:20852090.
  • 29
    Peiris DM, Lam W, Michael S, Ramanathan R. 2004. Distinguishing N-oxide and hydroxyl compounds: Impact of heated capillary/heated ion transfer tube in inducing atmospheric pressure ionization source decompositions. J Mass Spectrom 39:600606.
  • 30
    Ma S, Chowdhury SK, Alton KB. 2005. Thermally induced N-to-O rearrangement of tert-N-oxides in atmospheric pressure chemical ionization and atmospheric pressure photoionization mass spectrometry: Differentiation of N-oxidation from hydroxylation and potential determination of N-oxidation site. Anal Chem 77:36763682.
  • 31
    Cantu MD, Hillebrand S, Carrilho E. 2005. Determination of the dissociation constants (pKa) of secondary and tertiary amines in organic media by capillary electrophoresis and their role in the electrophoretic mobility order inversion. J Chromatogr A 1068:99105.
  • 32
    Oakes KD, Coors A, Escher BI, Fenner K, Garric J, Gust M, Knacker T, Küster A, Kussatz C, Metcalfe CD, Monteiro S, Moon TW, Mennigen JA, Parrott J, Péry ARR, Ramil M, Roennefahrt I, Tarazona JV, Sánchez-Argüello P, Ternes TA, Trudeau VL, Boucard T, Van Der Kraak GJ, Servos MR. 2010. Environmental risk assessment for the serotonin re-uptake inhibitor fluoxetine: Case study using the European risk assessment framework. Integr Environ Assess Manag 6:524539.